|
WO2021030702A1
|
|
Drinkable supplement composition for improved health and hydration
|
|
WO2021030258A1
|
|
Production of fatty acid esters using a yeast culture
|
|
WO2021030250A1
|
|
Methods for increasing the bioavailability of otc and pharmaceutical drugs
|
|
WO2021030232A1
|
|
Olfactory delivery of therapeutic compounds to the central nervous system
|
|
US2020396991A1
|
|
Production of mel-like glycolipids and lipopeptides using a bacillus sp. microorganism
|
|
US2020399526A1
|
|
Co-cultivation of a myxobacterium and acinetobacter for enhanced production of emulsan
|
|
WO2020257109A1
|
|
Co-culture of myxobacteria and pseudomonas for enhanced production of biosurfactants and other metabolites
|
|
WO2020231786A1
|
|
Compositions and methods for treating biofilm-related lung conditions
|
|
WO2020214685A1
|
|
Microbe-based emulsifying food additives
|
|
WO2020205815A1
|
|
Co-culture of myxobacteria and bacillus for enhanced metabolite production
|
|
WO2020210074A1
|
|
Pasture treatments for enhanced carbon sequestration and reduction in livestock-produced greenhouse gas emissions
|
|
WO2020198463A1
|
|
Remediation of food production and processing effluents and waste products
|
|
WO2020190699A1
|
|
Materials and methods for enhanced treatment and prevention of biofilms
|
|
WO2020185858A1
|
|
Materials and methods for producing cardiolipin-like phospholipids
|
|
WO2020172543A1
|
|
Novel methods for production of mannosylerythritol lipids
|
|
WO2020160226A1
|
|
Method for treating and/or preventing bacteriophage lysis during fermentation
|
|
WO2020159842A1
|
|
Production and use of yeast extract as a medical adjuvant
|
|
WO2020150121A1
|
|
Use of peanut hearts as a fermentation biostimulant
|
|
WO2020146219A1
|
|
Emulsified water-in-diesel composition
|
|
WO2020112777A1
|
|
Compositions and methods for enhancing quality of bread and baked goods
|
